Eczema, Atopic Clinical Trial
Official title:
The Effectiveness of a Topical Palmitoylethanolamide Formulation (Levagen+) for Reducing the Symptoms of Eczema Versus a Comparator
This is a double blind, randomised, non-clinical study with 2 groups (1 investigational group and 1 comparator group) aiming to assess the effectiveness of PEA for reducing eczema severity compared to a base comparator moisturiser in healthy adults aged over 18 years.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03568136 -
Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis
|
Phase 2 | |
| Recruiting |
NCT05575882 -
Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream Intended for Very Dry, Irritated to Atopic Sensitive Skin.
|
N/A | |
| Recruiting |
NCT06436183 -
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
|
Phase 2 | |
| Recruiting |
NCT05642208 -
Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis
|
Phase 4 | |
| Active, not recruiting |
NCT05913791 -
Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With Eczema
|
N/A | |
| Completed |
NCT00560378 -
Long-term Safety of Protopic in Atopic Eczema
|
Phase 3 | |
| Terminated |
NCT00671528 -
Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)
|
Phase 4 | |
| Terminated |
NCT05732454 -
A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection
|
Phase 2/Phase 3 | |
| Completed |
NCT03050151 -
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
|
Phase 1 | |
| Completed |
NCT03175354 -
A Study in Subjects With Moderate Atopic Dermatitis
|
Phase 2 |